111 results
10-K
2023 FY
EX-10.30
OCX
Oncocyte Corporation
Annual report
15 Apr 24
9:55pm
10-K
2023 FY
EX-10.28
OCX
Oncocyte Corporation
Annual report
15 Apr 24
9:55pm
10-K
2023 FY
EX-10.29
OCX
Oncocyte Corporation
Annual report
15 Apr 24
9:55pm
8-K
EX-10.2
OCX
Oncocyte Corporation
12 Apr 24
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
6:04am
8-K
EX-10.1
OCX
Oncocyte Corporation
12 Apr 24
Oncocyte Corporation Announces $15.8 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
6:04am
8-K
EX-10.1
ljjhydvsr9lo33 8ry
14 Jul 23
Departure of Directors or Certain Officers
6:03am
8-K
EX-10.1
9joq jko74
8 Jun 23
Departure of Directors or Certain Officers
6:29pm
8-K
EX-10.1
h39u830m 5knw
6 Apr 23
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-10.1
fivk 2e9ddnq
13 Feb 23
Entry into a Material Definitive Agreement
4:07pm
8-K
EX-10.1
k5xqlvq8
3 Feb 23
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.2
l158ei
21 Dec 22
Oncocyte Announces Initiatives to Focus Corporate Strategy
6:05am
8-K
EX-10.1
dmzoea zqg
21 Dec 22
Oncocyte Announces Initiatives to Focus Corporate Strategy
6:05am
8-K
EX-10.3
3u478q3j1i7
21 Dec 22
Oncocyte Announces Initiatives to Focus Corporate Strategy
6:05am
8-K
EX-10.3
eq40j4 g26ltz2hmzel
5 Dec 22
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.4
3s5hprzqfwyepu989hw
5 Dec 22
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.2
7kawlz xhgl6qt
5 Dec 22
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
5mc uqdds
5 Dec 22
Departure of Directors or Certain Officers
4:05pm
8-K
EX-10.1
em11 y9nk
13 Apr 22
Oncocyte Corporation Announces Pricing of Registered Direct Offering of 11,765 Shares of Series A Convertible Preferred Stock
5:09pm